Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go:
Expired
investment:
Withheld
Antikor is developing a new cancer treatment using antibody fragment drug conjugate which penetrates solid tumours to destroy cancer cells. Their new treatment only targets pre-determined cancer cells, so healthy cells are not affected. Biopharma is predicted to become the core of the pharmaceutical industry after undergoing transformation in the laboratory, technology and operations
days to go:
Expired
investment:
£125,000
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.
days to go:
Expired
investment:
£575,000
Arcade is an innovative provider of technology (patent pendinG) that empowers telecom carriers to offer life-changing gigabit broadband over existing networks, with rapid deployment and ROI in under a year. Their solutions enable gigabit speeds everywhere, complementing fiber strategies and avoiding extensive cable replacements.
days to go:
Expired
investment:
£350,000
Arkivum Limited is a cloud-based Software as a Service (SaaS) that provides specialist digital archiving and preservation services to customers in highly regulated industries, such as pharmaceuticals. Arkivum asserts that its software ensures that the digital content of its customers is safeguarded, usable, and auditable for decades into the future. Arkivum argues that its focus area is archiving clinical trial data for pharmaceutical companies, centring around Electronic Trial Master File (eTMF) that contain tens of thousands of different types of documents and overseen closely by drug sponsors. The company further claims that its services triumph over those offered by Amazon Web Services (AWS), Google Cloud Platform (GCP) and Microsoft Azure. Arkivum points out that its services have led to the company earning £1.4 million as Annual Recurring Revenue (ARR) as of March 2021. Arkivum is seeking to raise up to £1.075 million of equity to grow its business across different verticals.
days to go:
Expired
investment:
Withheld
Aveqia is a unique interactive gastronomic experience combining a luxury restaurant with state of the art kitchens to create an exceptional venue for corporate events or private groups. These experiences are run by Michelin star trained chefs.
days to go:
Expired
investment:
£100,000
Aveqia London is a unique interactive gastronomic experience combining a luxury restaurant with state of the art kitchens to create an exceptional venue for corporate events or private groups. Aveqia gives clients or colleagues the opportunity to work together to prepare and consume cuisine.
days to go:
Expired
investment:
£100,000
Better Nature Limited, also known as BN, is a foodtech company dedicated to creating Europe's leading tempeh brand – a protein-rich, all-natural meat substitute made from fermented soybeans. With its delicious taste and meat-like texture gaining popularity in the US, BN aims to expand its presence in the UK and Europe. BN's unique focus on tempeh fermentation, supported by patented technology, sets it apart, allowing the development of a variety of consumer and B2B products. Unlike niche alternatives, BN positions its tempeh as an everyday, affordable option for a wide audience, with products available in numerous retail locations, including major retailers and distributors.
days to go:
Expired
investment:
Withheld
Bikecation was formed in 2011 and specialise in package and bespoke cycling holidays in the UK and Europe. They aim to provide holidays that capture the freedom and fun of cycling with a holiday that give you a thirst of adventure and an appetite for great food.
days to go:
Expired
investment:
£70,000
Billon have created a technology that enables zero cost global payments by the use of a simple mobile app. Billon's mobile app allows you to instantly pay for the rest of an article from the Guardian or even donate to your favourite Youtubers with a few clicks of a button.
days to go:
Expired
investment:
£1,406,667
